Choosing Wisely:

Don’t perform Pap tests for surveillance of women with a history of endometrial cancer.

Rationale and Comments: Pap testing of the top of the vagina in women treated for endometrial cancer does not improve detection of local recurrence. False-positive Pap smears in this group can lead to unnecessary procedures such as colposcopy and biopsy.
Sponsoring Organizations:
  • Society of Gynecologic Oncology
  • Sources:
  • Society of Gynecologic Oncology guidelines
  • Disciplines:
  • Gynecologic
  • Oncologic
  • References: • Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204:466-78.
    • Salani R, Nagel CI, Drennen E, Bristow RE. Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol. 2011;123:205-7.
    • Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL II. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006;103:709-13.

    Email Alerts

    Don't miss a single issue. Sign up for the free AFP email table of contents.

    Sign Up Now